Agilent Technologies Overview
Valuation check: A's ROE is 19.56%, above the Healthcare sector average of 11.15%.
Get informed when a big investor buys or sells
+ Follow19.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Agilent Technologies (A) currently reports a ROE of 19.56%. That is above the Healthcare sector average of 11.15%. Use the charts on this page to explore Agilent Technologies's ROE history and peer comparisons.
Agilent Technologies's ROE of 19.56% is higher than the Healthcare sector average of 11.15%. That is roughly 75.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Agilent Technologies's current 19.56% should be judged against Healthcare norms (sector average: 11.15%) and against A's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 19.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for Agilent Technologies, and consider following A for alerts when major investors trade the stock.
Agilent Technologies is classified in the Healthcare sector. On ROE, it currently shows 19.56% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing A with unrelated industries.
